We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$28.5B
AUM Growth
+$2.42B
Cap. Flow
+$581M
Cap. Flow %
2.04%
Top 10 Hldgs %
19.66%
Holding
1,921
New
171
Increased
1,320
Reduced
356
Closed
71

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$111M
2
VFC icon
VF Corp
VFC
+$73.4M
3
AMZN icon
Amazon
AMZN
+$71M
4
SWK icon
Stanley Black & Decker
SWK
+$60.2M
5
TSLA icon
Tesla
TSLA
+$46.2M

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$158M
2
AAPL icon
Apple
AAPL
+$130M
3
CAH icon
Cardinal Health
CAH
+$43.7M
4
FTNT icon
Fortinet
FTNT
+$39.6M
5
XOM icon
ExxonMobil
XOM
+$32.1M

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Industrials 12.07%
3 Consumer Staples 11.64%
4 Healthcare 11.12%
5 Financials 10.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVT icon
1476
InvenTrust Properties
IVT
$2.84B
$206K ﹤0.01%
+8,720
New +$208K
BSY icon
1477
Bentley Systems
BSY
$9.54B
$206K ﹤0.01%
+5,584
New +$202K
BBT
1478
Beacon Financial Corp
BBT
$2.53B
$206K ﹤0.01%
+6,899
New +$203K
FCF icon
1479
First Commonwealth Financial
FCF
$2.12B
$206K ﹤0.01%
14,740
+1,901
+15% +$26.8K
PRAA icon
1480
PRA Group
PRAA
$648M
$206K ﹤0.01%
+6,094
New +$201K
LOPE icon
1481
Grand Canyon Education
LOPE
$3.71B
$206K ﹤0.01%
+1,947
New +$194K
CRNX icon
1482
Crinetics Pharmaceuticals
CRNX
$8.86B
$205K ﹤0.01%
11,222
+913
+9% +$16.1K
DEA
1483
Easterly Government Properties
DEA
$1.18B
$205K ﹤0.01%
5,751
+741
+15% +$28.8K
DGII icon
1484
Digi International
DGII
$2.52B
$205K ﹤0.01%
+5,601
New +$216K
TCBK icon
1485
TriCo Bancshares
TCBK
$1.85B
$205K ﹤0.01%
+4,014
New +$209K
CRVL icon
1486
CorVel
CRVL
$3.05B
$204K ﹤0.01%
+4,221
New +$210K
NBHC icon
1487
National Bank Holdings
NBHC
$1.93B
$204K ﹤0.01%
+4,860
New +$210K
IRBT
1488
DELISTED
iRobot
IRBT
$204K ﹤0.01%
4,247
+547
+15% +$28.9K
XENE icon
1489
Xenon Pharmaceuticals
XENE
$6.32B
$204K ﹤0.01%
+5,172
New +$188K
OFG icon
1490
OFG Bancorp
OFG
$2.21B
$203K ﹤0.01%
+7,383
New +$203K
RBLX icon
1491
Roblox
RBLX
$34B
$203K ﹤0.01%
7,146
-209
-3% -$7.34K
FBK icon
1492
FB Financial Corp
FBK
$2.95B
$203K ﹤0.01%
+5,627
New +$225K
NUVL
1493
DELISTED
Nuvalent
NUVL
$203K ﹤0.01%
+6,808
New +$190K
TGTX icon
1494
TG Therapeutics
TGTX
$8.58B
$203K ﹤0.01%
17,129
+2,443
+17% +$17.7K
HLIT icon
1495
Harmonic Inc
HLIT
$1.21B
$202K ﹤0.01%
15,443
+1,868
+14% +$26.1K
FATE icon
1496
Fate Therapeutics
FATE
$281M
$202K ﹤0.01%
19,983
+1,347
+7% +$25.3K
VISN
1497
Vistance Networks Inc
VISN
$2.66B
$202K ﹤0.01%
27,429
+3,693
+16% +$35.6K
XPEL icon
1498
XPEL
XPEL
$1.18B
$201K ﹤0.01%
+3,342
New +$213K
LRN icon
1499
Stride
LRN
$3.69B
$201K ﹤0.01%
6,415
+834
+15% +$30.6K
DVAX
1500
DELISTED
Dynavax Technologies
DVAX
$200K ﹤0.01%
18,840
+2,591
+16% +$30.1K

Similar funds

ProShare Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, ProShare Advisors held 1,921 positions worth $28.5B, up 9.3% from $26.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

ProShare Advisors's Q4 2022 filing shows 171 new, 1,320 increased, 356 reduced and 71 closed positions. Its largest new stake was Rivian: 689,839 shares worth $12.7M. The largest sale was Target, an estimated $158M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Industrials and Consumer Staples.

  • ProShare Advisors's largest Q4 2022 buy was Rivian: 689,839 shares worth $12.7M.
  • ProShare Advisors added most to Microsoft in Q4 2022, an estimated $111M increase.
  • ProShare Advisors's biggest Q4 2022 reduction was Apple, cutting an estimated $130M.
  • ProShare Advisors fully exited Target in Q4 2022, selling an estimated $158M.
  • ProShare Advisors's ten largest holdings make up 20% of its $28.5B portfolio in Q4 2022.
  • ProShare Advisors opened 171 new positions and closed 71 in Q4 2022.
  • ProShare Advisors's portfolio value rose 9.3% quarter-over-quarter to $28.5B.

Based on ProShare Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.